Group 6 Copy 112
-1
Please wait...

About This Project

OncoSynergy, Inc.
The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
Blast off!

Browse Other Projects on Experiment

Related Projects

How does the struggle between sexual selection and natural selection drive the coloration of a tropical gecko?

On animal coloration, sexual selection may promote conspicuousness while natural selection may favor crypsis...

Organofoam: Can we improve biodegradable fungal styrofoam substitutes?

Petroleum-based materials such as Styrofoam, while convenient, seriously threaten our environment, releasing...

Probiotics for plants? Fighting insects by boosting corn immune systems

Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

Backer Badge Funded

A biology project funded by 47 people